Sign in
CompletedPhase 1

Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 1

Key facts

Who runs it
Yale University
Where
West Haven, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 1
People taking part
10 people enrolled
Started
26 Jan 2024
Ended
31 Dec 2025
Type of study
Interventional, 4 groups
Treatments tested
  • Bupivacaine Injection
Record updated
20 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • United States Military Veterans within VA Connecticut Healthcare System
  • Chronic post-traumatic headache per ICHD-3 criteria (i.e., headaches are continuing to occur three months after the head injury)
  • At least two headache days per week
  • MRI brain scan completed within the past 3 months if chronic PTH for less than one year, within the past year if chronic PTH for less than 5 years, and within 5 years if chronic PTH for more than 10 years
  • Review of MRI and the medical record does not reveal another source for headache

Who cannot take part

  • Other contraindication to bupivacaine; Allergy or adverse reaction (e.g., rash, cardiac effects) to amide anesthetics, such as lidocaine; Instruction from clinician to avoid amide anesthetics, such as lidocaine
  • Skull defect
  • Pregnant or lack of adequate birth control

Where in United States

  • VA Connecticut Healthcare SystemWest Haven, United States

About the trial

What the trial wants to find out

The acute and subacute sensations that occur on the scalp with injection of different concentrations of bupivacaine for grater occipital nerve blockade will be compared. Each Veteran participant will be randomized to receive three different concentrations, which will be injected one week apart each.

The 4 groups in the trial

  • Group 1Treatment being tested

    bupivacaine 0.0%, 0.01%, and 0.05% in random order, one week apart each

    Treatment: Bupivacaine Injection

  • Group 2Treatment being tested

    bupivacaine 0.1%, 0.05%, and 0.1% in random order, one week apart each

    Treatment: Bupivacaine Injection

  • Group 3Treatment being tested

    bupivacaine 0.0%, 0.1%, and 0.5% in random order, one week apart each

    Treatment: Bupivacaine Injection

  • Group 4Treatment being tested

    bupivacaine \[0.01% or 0.05%\], \[0.05% or 0.1%\], and 0.05% in random order, one week apart each

    Treatment: Bupivacaine Injection

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Anesthetic Greater Occipital Nerve Blockade in Veterans With Post-Traumatic Headache: Sub-study 1
Record updated
20 August 2026